US2009176966A1PendingUtilityA1

Natural IGM Antibodies and Inhibitors Thereof

59
Individually held — no corporate assignee on recordPriority: Mar 1, 2004Filed: Oct 28, 2008Published: Jul 9, 2009
Est. expiryMar 1, 2024(expired)· nominal 20-yr term from priority
Inventors:Michael C. CarrollFrancis D. Moore, Jr.Herbert B. Hechtman
A61P 9/10A61P 43/00A61K 2039/57C07K 16/18A61K 2039/505A61P 29/00C07K 16/00A61K 38/00C07K 7/08C07K 2317/52C07K 2317/34C07K 16/28A61K 39/00
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides natural IgM antibody inhibitors that may be used to treat various inflammatory diseases or disorders.

Claims

exact text as granted — not AI-modified
1 .- 13 . (canceled) 
     
     
         14 . A composition comprising a peptide having the amino acid sequence of SEQ ID NOs: 14, 16, 18, 20, 22, 24, 26, 28, 30, or 32. 
     
     
         15 .- 17 . (canceled) 
     
     
         18 . The composition of  claim 14 , wherein the peptide is pegylated. 
     
     
         19 . The composition of  claim 14 , wherein the peptide is labeled with a detectable label. 
     
     
         20 - 47 . (canceled)

Join the waitlist — get patent alerts

Track US2009176966A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.